SB-277011

CAS No. 215803-78-4

SB-277011( SB-277011-A | SB-277011A | SB277011 | SB 277011 )

Catalog No. M13441 CAS No. 215803-78-4

A potent and selective dopamine D3 receptor antagonist with pKi of 8.0.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 52 In Stock
5MG 50 In Stock
10MG 81 In Stock
25MG 152 In Stock
50MG 248 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SB-277011
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective dopamine D3 receptor antagonist with pKi of 8.0.
  • Description
    A potent and selective dopamine D3 receptor antagonist with pKi of 8.0; displays >100-fold selectivity against the D2, 5-HT1B, and 5-HT1D receptors; exhibits high oral bioavailability and brain penetration in rats.Schizophrenia Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SB-277011-A | SB-277011A | SB277011 | SB 277011
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor
  • Research Area
    Neurological Disease
  • Indication
    Schizophrenia

Chemical Information

  • CAS Number
    215803-78-4
  • Formula Weight
    438.564
  • Molecular Formula
    C28H30N4O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C1CC(CCC1CCN2CCC3=C(C2)C=CC(=C3)C#N)NC(=O)C4=CC=NC5=CC=CC=C45
  • Chemical Name
    4-Quinolinecarboxamide, N-[trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Stemp G, et al. J Med Chem. 2000 May 4;43(9):1878-85. 2. Reavill C, et al. J Pharmacol Exp Ther. 2000 Sep;294(3):1154-65. 3. Ashby CR Jr, et al. J Pharmacol Exp Ther. 2000 Sep;294(3):1166-74.
molnova catalog
related products
  • Benztropine mesylate

    Benzatropine is an anticholinergic drug used in patients to reduce the side effects of antipsychotic treatment.

  • Metoclopramide

    A potent dopamine D2 receptor antagonist with Ki of 28 nM; also is a mixed 5-HT3 receptor antagonist/5-HT4 receptor agonist.

  • Abaperidone

    Abaperidone is a potent 5-HT2A receptor and dopamine D2 receptor antagonist with an IC50 of 6.2 for 5-HT2A receptors and 17 nM for dopamine D2 receptors.